Cargando…
Targeted O-glycoproteomics for the development of diagnostic markers for advanced colorectal cancer
Aberrant glycosylation is a prominent feature of cancer, that can be used as targets to improve the existing cancer biomarkers, and help to assess metastasis risks, and therapeutic effects. We developed a targeted O-glycoproteomics method using serum specimens, and evaluated its utility in identifyi...
Autores principales: | Takakura, Daisuke, Ohashi, Shoko, Kobayashi, Noritoshi, Tokuhisa, Motohiko, Ichikawa, Yasushi, Kawasaki, Nana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948623/ https://www.ncbi.nlm.nih.gov/pubmed/36845686 http://dx.doi.org/10.3389/fonc.2023.1104936 |
Ejemplares similares
-
Comprehensive Membrane N-Glycoproteomics Using Human Breast Cancer Cell Line Pairs
por: Takakura, Daisuke, et al.
Publicado: (2023) -
Sorafenib Monotherapy in a Patient with Unresectable Hepatic Epithelioid Hemangioendothelioma
por: Kobayashi, Noritoshi, et al.
Publicado: (2016) -
Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumors
por: Kobayashi, Noritoshi, et al.
Publicado: (2021) -
Effect of FOLFIRINOX as second-line chemotherapy for metastatic pancreatic cancer after gemcitabine-based chemotherapy failure
por: Kobayashi, Noritoshi, et al.
Publicado: (2017) -
Case reports: chemoradiotherapy for locally advanced neuroendocrine carcinoma of the gallbladder
por: Takeda, Yuma, et al.
Publicado: (2022)